CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.380
+0.440 (22.68%)
At close: Aug 15, 2025, 4:00 PM
2.000
-0.380 (-15.97%)
After-hours: Aug 15, 2025, 7:59 PM EDT
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $36.87 million as of August 15, 2025. Its market cap has decreased by -60.85% in one year.
Market Cap
36.87M
Enterprise Value
42.67M
1-Year Change
-60.85%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $36.87M, a decrease of -63.77%. That is a compound annual growth rate of -3.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 36.87M | -15.90% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | 365.63M | 22.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 632.50B |
| Johnson & Johnson | 425.84B |
| AbbVie | 364.25B |
| UnitedHealth Group | 279.62B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Abbott Laboratories | 228.87B |
| Novo Nordisk | 225.09B |